Clinical trials: Erythema Multiforme
Plaque Psoriasis
A Study of DLX105-DMP in Subjects With Plaque Psoriasis
A Pilot, Open-Label Study in Subjects with Mild-to-Moderate Plaque Psoriasis to Investigate the Safety, Tolerability, and Preliminary Efficacy of a Four-Week Multidose Regimen of DLX105-DMP Administered to a Target Lesion
- Trial name
- NCT04203433
- Testing
- DLX105-DMP
- Where
- 4 sites in United States
- Volunteers
- 10 people
- Sponsor
- DelArrivo, Inc.